as compared with the placebo group , the treatment group had increases in median bone mineral density of 35 percent ( p less than 0.0001 ) in the lumbar spine ( predominantly cancellous bone ) , 12 percent ( p less than 0.0001 ) in the femoral neck , and 10 percent ( p less than 0.0001 ) in the femoral trochanter ( sites of mixed cortical and cancellous bone ) , but the bone mineral density decreased by 4 percent ( p less than 0.02 ) in the shaft of the radius ( predominantly cortical bone ) .
C0015811
femoral
C0162370
trochanter